Key result
Pretreatment with a combination of benidipine and edaravone significantly attenuated cardiac biomarkers, oxidative stress, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats.
Why the study?
Does pretreatment with a combination of benidipine and edaravone attenuate isoproterenol-induced myocardial infarction in Wistar rats?
Does pretreatment with a combination of benidipine and edaravone attenuate isoproterenol-induced myocardial infarction in Wistar rats?
p-value: p=<0.01
The combination of benidipine and edaravone protects against isoproterenol-induced myocardial infarction in rats by reducing oxidative stress, inflammation, and apoptosis.
Should not yet change practice in myocardial infarction; hypothesis-generating for combined benidipine-edaravone cardioprotection.
OBJECTIVES: In the present study, we investigated whether combination therapy of low-dose benidipine with the potent free radical scavenger edaravone has a cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in Wistar rats. METHODS: Rats were pretreated with concurrent doses of benidipine and edaravone (1 μg/kg/day + 1 mg/kg/day and 3 μg/kg/day + 3 mg/kg/day) by intravenous (i.v.) and intraperitoneal (i.p.) routes respectively for 28 days, followed by MI induction using ISO (85 mg/kg) by subcutaneous route for two days at 24 h intervals. After the treatment period, blood was withdrawn and the heart was preserved for biochemical estimations. RESULTS: The activities of the cardiac biomarkers (lactate dehydrogenase and creatine kinase-MB), and the level of malondialdehyde (MDA) significantly increased, while antioxidant markers (reduced glutathione, catalase, superoxidase dismutase, glutathione peroxidase, glutathione reductase) were significantly decreased in the ISO intoxicated group compared with the control group. Moreover, the level of C-reactive protein (CRP) and Caspase-3 activity significantly increased in ISO-intoxicated group. An ultrastructure study was also carried out. Pretreatment with a combination of benidipine and edaravone significantly attenuated the activities of the cardiac biomarkers and the level of MDA, and significantly increased the antioxidant markers compared with the ISO-intoxicated group. Furthermore, pretreatment with the combination of benidipine and edaravone significantly decreased the level of CRP and Caspase-3 activity as compared to the ISO-treated group. The ultrastructure study of myocardium revealed that pretreated groups preserved the mitochondrial shape, the membrane and its internal structures. CONCLUSION: Taken together these results suggest that the combination of benidipine and edaravone showed significant protective effect in ISO-induced MI.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2016) studied Isoproterenol-induced myocardial infarction (n=36). Benidipine and edaravone combination vs. Isoproterenol (ISO) alone was evaluated on Cardiac biomarkers, oxidative stress markers, and apoptotic markers (p=<0.01). Pretreatment with a combination of benidipine and edaravone significantly attenuated cardiac biomarkers, oxidative stress, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: